LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 128 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $20,595,000 | -55.0% | 267,090 | -68.9% | 4.31% | -51.6% |
| Q4 2014 | $45,764,000 | -12.2% | 860,063 | -22.4% | 8.90% | -17.7% |
| Q3 2014 | $52,101,000 | -55.8% | 1,108,763 | -41.4% | 10.82% | -42.0% |
| Q2 2014 | $117,923,000 | -16.4% | 1,893,123 | -9.7% | 18.65% | -14.7% |
| Q1 2014 | $141,005,000 | +2.1% | 2,096,416 | -20.2% | 21.86% | -9.6% |
| Q4 2013 | $138,136,000 | +1.2% | 2,626,160 | -16.7% | 24.17% | +2.9% |
| Q3 2013 | $136,491,000 | +0.7% | 3,153,665 | -12.9% | 23.48% | -10.7% |
| Q2 2013 | $135,523,000 | – | 3,621,665 | – | 26.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |